title: Rituximab-induced coagulopathy.
authors.forename: Jan
authors.initials: J
authors.lastname: Novak
authors.forename: Heidi
authors.initials: H
authors.lastname: Mocikova
authors.forename: Petr
authors.initials: P
authors.lastname: Pavlicek
authors.forename: Lubica
authors.initials: L
authors.lastname: Gaherova
authors.forename: Tomas
authors.initials: T
authors.lastname: Kozak
mesh_terms: D000368:Aged; D058846:Antibodies, Monoclonal, Murine-Derived / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001778:Blood Coagulation Disorders / Q000139:chemically induced*; D006801:Humans; D008297:Male; D000069283:Rituximab; D008258:Waldenstrom Macroglobulinemia / Q000188:drug therapy*
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab